Skip to main content
. 2021 Jun 10;39(9):973–982. doi: 10.1007/s40273-021-01046-1

Table 2.

Decision rules for the definition of risk-sharing arrangements

Uncertainty type Objectives Proposed model
Uncertainty concerning health outcomes Limit and share the risk over short-term, medium-term, and long-term health outcomes PBRSA (e.g., PLRS or coverage with evidence development)
Uncertainty concerning financial outcomes Limit and share the risk of unexpected growth of estimated BI due to variations in posology or treatment duration CSA (e.g., price volume, budget and/or utilization capping) or conventional payment with simple discount based on clinical outcomes
Limit and share the risk of unexpected growth of estimated BI due to unforeseen use extensions and the patient population CSA (e.g., price volume, budget or/and utilization capping), conventional payment with simple discount based on clinical outcomes and/or access restriction concerning patient subgroups

BI budgetary impact, CSA cost-sharing arrangement, PLRS performance-linked reimbursement scheme, PBRSA performance-based risk-sharing arrangement